title: Effects of an inactivated porcine circovirus type 2 (PCV2) vaccine on PCV2 virus shedding in semen from experimentally infected boars.
abstract: The objective of the present study was to determine the effect of an inactivated porcine circovirus type 2 (PCV2) vaccine on PCV2b virus shedding in the semen of experimentally infected boars by measuring the immunological response and the PCV2b DNA load in blood and semen. Twelve boars were randomly divided into three groups. The boars in group 1 (n = 4) were immunized with an inactivated PCV2 vaccine and were challenged with PCV2b. The boars in group 2 (n = 4) were only challenged with PCV2b. The boars in group 3 (n = 4) served as negative controls. The number of PCV2 genome copies of PCV2 in the serum and semen were significantly lower in vaccinated challenged boars than in nonvaccinated challenged boars at 7, 10, 14, 21, 32, 35, 42, 49, and 60 days postinoculation. The number of PCV2b genomes in the semen correlated with the number of PCV2b genomes in the blood in both vaccinated challenged (R = 0.714) and nonvaccinated challenged (R = 0.861) boars. The results of the present study demonstrate that the inactivated PCV2 vaccine significantly decreases the amount of PCV2b DNA shedding in semen from vaccinated boars after experimental infection with PCV2b.
authors: Department of Veterinary Pathology, College of Veterinary Medicine, Seoul National University, 599 Gwanak-ro, Gwanak-gu, Seoul 151-742, Republic of Korea.
authors: Hwi Won
authors: HW
authors: Seo
authors: Kiwon
authors: K
authors: Han
authors: Duyeol
authors: D
authors: Kim
authors: Yeonsu
authors: Y
authors: Oh
authors: Ikjae
authors: I
authors: Kang
authors: Changhoon
authors: C
authors: Park
authors: Hyun
authors: H
authors: Jang
authors: Chanhee
authors: C
authors: Chae
references: J Vet Diagn Invest. 2008 Nov;20(6):725-34
references: 18987221
references: J Virol Methods. 2008 May;149(2):217-25
references: 18355929
references: J Vet Med Sci. 2003 Jun;65(6):741-4
references: 12867738
references: J Vet Diagn Invest. 2010 Mar;22(2):231-3
references: 20224081
references: Vaccine. 2008 Mar 10;26(11):1488-99
references: 18304705
references: Vet J. 2005 May;169(3):326-36
references: 15848776
references: J Anim Sci. 2011 May;89(5):1581-7
references: 21169515
references: Vet Microbiol. 2008 Sep 18;131(1-2):103-14
references: 18430525
references: Vaccine. 2009 Feb 11;27(7):1002-7
references: 19100807
references: Vet Res. 2009 Jan-Feb;40(1):10
references: 18973743
references: Theriogenology. 2005 Jan 15;63(2):283-99
references: 15626400
references: J Comp Pathol. 2003 Jan;128(1):52-9
references: 12531687
references: Vet Microbiol. 2010 May 19;142(3-4):177-83
references: 19913369
references: Clin Vaccine Immunol. 2008 Mar;15(3):397-401
references: 18094109
references: Res Vet Sci. 2001 Jun;70(3):265-9
references: 11676625
references: Vaccine. 2009 Jun 19;27(30):4031-7
references: 19379787
references: Theriogenology. 2001 Nov 1;56(8):1305-10
references: 11758884
references: J Virol Methods. 2001 Oct;98(1):25-31
references: 11543881
references: J Vet Diagn Invest. 2008 Sep;20(5):545-58
references: 18776085